Intestinal expression of TFF and related genes during postnatal development in a piglet probiotic trial

Cellular Physiology and Biochemistry

Volumn 23, Issue 1-3, 2009, Pages 143-156

  Scholven, Jutta ^a   Taras, David ^a   Sharbati, Soroush ^a   Schön, Jennifer ^a   Gabler, Christoph ^a   Huber, Otmar ^b,c   Meyer Zum Büschenfelde, Dirk ^b   Blin, Nikolaus ^d   Einspanier, Ralf ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cyclooxygenase 2; Cytokines; Epidermal growth factor receptor; Intestinal development; TFF; Transforming growth factor alpha; Trefoil factor; Tumor necrosis factor alpha; Weaning

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROBIOTIC AGENT; TREFOIL FACTOR FAMILY 1; TREFOIL FACTOR FAMILY 2; TREFOIL FACTOR FAMILY 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENTEROCOCCUS FAECIUM; GENE EXPRESSION REGULATION; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE DEVELOPMENT; INTESTINE MUCOSA; JEJUNUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PIGLET; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; WEANING;

ENTEROCOCCUS FAECIUM; LOTUS; RODENTIA; SUS;

EID: 60549101900     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204103     Document Type: Article

References (71)

1. Ismail AS, Hooper LV: Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2005;289:G779-784.
2. Mammen JM, Matthews JB: Mucosal repair in the gastrointestinal tract. Crit Care Med 2003;31:S532-537.
3. Thim L: A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989;250:85-90.
4. Suemori S, Lynch-Devaney K, Podolsky DK: Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 1991;88:11017-11021.
5. Thim L, Woldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK: Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995;34:4757-4764.
6. Taupin D, Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003;4:721-732.
7. Wong WM, Poulsom R, Wright NA: Trefoil peptides. Gut 1999;44:890-895.
8. Hoffmann W: Trefoil factor family (TFF) peptides: regulators of mucosal regeneration and repair, and more. Peptides 2004;25:727-730.
9. Hoffmann W: Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 2005;62:2932-2938.
10. Meyer zum Buschenfelde D, Hoschutzky H, Tauber R, Huber O: Molecular mechanisms involved in TFF3 peptide-mediated modulation of the E-cadherin/ catenin cell adhesion complex. Peptides 2004;25:873-883.
11. Durer U, Hartig R, Bang S, Thim L, Hoffmann W: TFF3 and EGF induce different migration patterns of intestinal epithelial cells in vitro and trigger increased internalization of E-cadherin. Cell Physiol Biochem 2007;20:329-346.
12. Soriano-Izquierdo A, Gironella M, Massaguer A, May FE, Salas A, Sans M, Poulsom R, Thim L, Pique JM, Panes J: Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation. J Leukoc Biol 2004;75:214-223.
13. Blanchard C, Durual S, Estienne M, Bouzakri K, Heim MH, Blin N, Cuber JC: IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J Immunol 2004;172:3775-3783.
14. Baus-Loncar M, Al-azzeh ED, Romanska H, Lalani el N, Stamp GW, Blin N, Kayademir T: Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C/EBPbeta. Peptides 2004;25:849-854.
15. Baus-Loncar M, Giraud AS: Multiple regulatory pathways for trefoil factor (TFF) genes. Cell Mol Life Sci 2005;62:2921-2931.
16. Cook GA, Yeomans ND, Giraud AS: Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration. Am J Physiol 1997;272:G1540-1549.
17. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS: Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 1999;4:D303-309.
18. Goodlad RA, Wright NA: Epidermal growth factor and transforming growth factor-alpha actions on the gut. Eur J Gastroenterol Hepatol 1995;7:928-932.
19. Hormi K, Lehy T: Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut 1996;39:532-538.
20. Rodrigues S, Attoub S, Nguyen QD, Bruyneel E, Rodrigue CM, Westley BR, May FE, Thim L, Mareel M, Emami S, Gespach C: Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene 2003;22:4488-4497.
21. Tan XD, Chen YH, Liu QP, Gonzalez-Crussi F, Liu XL: Prostanoids mediate the protective effect of trefoil factor 3 in oxidant-induced intestinal epithelial cell injury: role of cyclooxygenase-2. J Cell Sci 2000;113 ( Pt 12):2149-2155.
22. Rodrigues S, Nguyen QD, Faivre S, Bruyneel E, Thim L, Westley B, May F, Flatau G, Mareel M, Gespach C, Emami S: Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. Faseb J 2001;15:1517-1528.
23. Playford RJ, Ghosh S: Cytokines and growth factor modulators in intestinal inflammation and repair. J Pathol 2005;205:417-425.
24. Loncar MB, Al-azzeh ED, Sommer PS, Marinovic M, Schmehl K, Kruschewski M, Blin N, Stohwasser R, Gott P, Kayademir T: Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide. Gut 2003;52:1297-1303.
25. Rasmussen TN, Raaberg L, Poulsen SS, Thim L, Holst JJ: Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig. Histochemistry 1992;98:113-119.
26. Sartor RB: Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44-50.
27. Nabuurs MJ: Weaning piglets as a model for studying pathophysiology of diarrhea. Vet Q 1998;20 Suppl 3:S42-45.
28. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241.
29. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007;9:804-816.
30. Madsen KL: The use of probiotics in gastrointestinal disease. Can J Gastroenterol 2001;15:817-822.
31. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK: Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-523.
32. Hoffmann W, Jagla W, Wiede A: Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 2001;16:319-334.
33. Einerhand AW, Renes IB, Makkink MK, van der Sluis M, Buller HA, Dekker J: Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 2002;14:757-765.
34. Caballero-Franco C, Keller K, De Simone C, Chadee K: The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G315-322.
35. Baus-Loncar M, Schmid J, Lalani el N, Rosewell I, Goodlad RA, Stamp GW, Blin N, Kayademir T: Trefoil factor 2 (TFF2) deficiency in murine digestive tract influences the immune system. Cell Physiol Biochem 2005;16:31-42.
36. Meyer zum Buschenfelde D, Tauber R, Huber O: TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression. Peptides 2006;27:3383-3390.
37. Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U: Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 2007;55:505-513.
38. Paulsen F, Varoga D, Paulsen A, Tsokos M: Trefoil factor family (TFF) peptides of normal human Vater's ampulla. Cell Tissue Res 2005;321:67-74.
39. Thim L, Jorgensen KH, Jorgensen KD: Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 1982;3:221-230.
40. Hruby L: A quantitative study of the relative growth of the small intenstine of the rat during the period of suckling. Folia Morphol (Praha) 1966;14:308-314.
41. Herbst JJ, Sunshine P: Postnatal development of the small intestine of the rat. Changes in mucosal morphology at weaning. Pediatr Res 1969;3:27-33.
42. Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA, Hoffmann W: hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A 1993;90:6961-6965.
43. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, De-Beaumont M, Sands BE, Mahida YR: Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:12230.
44. Lin J, Holzman IR, Jiang P, Babyatsky MW: Expression of intestinal trefoil factor in developing rat intestine. Biol Neonate 1999;76:92-97.
45. Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, Lathe R, Bellocq JP, Chambon P: Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991;100:375-379.
46. Wright NA, Poulsom R, Stamp GW, Hall PA, Jeffery RE, Longcroft JM, Rio MC, Tomasetto C, Chambon P: Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162:279-284.
47. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L: Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004;127:502-513.
48. Babyatsky MW, deBeaumont M, Thim L, Podolsky DK: Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 1996;110:489-497.
49. Pie S, Lalles JP, Blazy F, Laffitte J, Seve B, Oswald IP: Weaning is associated with an upregulation of expression of inflammatory cytokines in the intestine of piglets. J Nutr 2004;134:641-647.
50. Cummins AG, Thompson FM: Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut 2002;51:748-754.
51. FitzGerald AJ, Pu M, Marchbank T, Westley BR, May FE, Boyle J, Yadollahi-Farsani M, Ghosh S, Playford RJ: Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis. Peptides 2004;25:793-801.
52. Chailler P, Menard D: Ontogeny of EGF receptors in the human gut. Front Biosci 1999;4:D87-101.
53. Oliver AM: Epidermal growth factor receptor expression in human foetal tissues is age-dependent. Br J Cancer 1988;58:461-463.
54. Gallo-Payet N, Pothier P, Hugon JS: Ontogeny of EGF receptors during postnatal development of mouse small intestine. J Pediatr Gastroenterol Nutr 1987;6:114-120.
55. Malo C, Menard D: Influence of epidermal growth factor on the development of suckling mouse intestinal mucosa. Gastroenterology 1982;83:28-35.
56. Menard D, Pothier P, Gallo-Payet N: Epidermal growth factor receptors during postnatal development of the mouse colon. Endocrinology 1987;121:1548-1554.
57. Steinkamp M, Reinshagen M: Transforming growth factor-alpha in the regulation of enterocytic proliferation: part of a puzzle. Eur J Gastroenterol Hepatol 2001;13:1285-1287.
58. Hoffmann P, Zeeh JM, Lakshmanan J, Wu VS, Procaccino F, Reinshagen M, McRoberts JA, Eysselein VE: Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats. Gut 1997;41:195-202.
59. Dignass AU, Stow JL, Babyatsky MW: Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor alpha and beta. Gut 1996;38:687-693.
60. Polk WH, Jr., Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, Coffey RJ, Jr.: Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992;102:1467-1474.
61. Babyatsky MW, Rossiter G, Podolsky DK: Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975-984.
62. Schaeffer C, Habold C, Martin E, Lignot JH, Kedinger M, Foltzer-Jourdainne C: Cytokine expression in rat colon during postnatal development: regulation by glucocorticoids. J Pediatr Gastroenterol Nutr 2006;43:439-450.
63. Schaeffer C, Diab-Assef M, Plateroti M, Laurent-Huck F, Reimund JM, Kedinger M, Foltzer-Jourdainne C: Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids. Gut 2000;47:192-198.
64. FAO/WHO: Evaluation of health and nutritional properties of powder milk and live lactic bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report 2001.
65. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C: Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-591.
66. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L, Shanahan F: Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006;118:202-215.
67. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ: Immune response induced by Bifidobacterium strains isolated from infants in gnotobiotic mice. Appl Environ Microbiol 2007.
68. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR: New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003;37:105-118.
69. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999;276:G941-950.
70. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA: Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800.
71. Hoffmann W, Jagla W: Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 2002;213:147-181.